243 related articles for article (PubMed ID: 15633221)
1. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
2. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
Zhao P; Song X; Nin YY; Lu YL; Li XH
World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
5. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between FHIT and WWOX expression and clinicopathological features in hepatocellular carcinoma].
Lin J; Wang B; Huang AM; Wang XJ
Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
[TBL] [Abstract][Full Text] [Related]
7. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
8. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
Nam CW; Shin JW; Park NH
World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
[TBL] [Abstract][Full Text] [Related]
9. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
10. FHIT mRNA and protein expression in hepatocellular carcinoma.
Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M
Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557
[TBL] [Abstract][Full Text] [Related]
11. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
12. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer.
Toledo G; Sola JJ; Lozano MD; Soria E; Pardo J
Mod Pathol; 2004 Apr; 17(4):440-8. PubMed ID: 14976524
[TBL] [Abstract][Full Text] [Related]
13. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
15. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes.
Bai Y; Shen Y; Yuan Q; Lv C; Xing Q
Med Sci Monit; 2019 Feb; 25():1301-1306. PubMed ID: 30773529
[TBL] [Abstract][Full Text] [Related]
17. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell].
Wang Y; Zhou Q; Zhang S; Yang H; Cheng N; Li L; Wu Z; Liu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):178-82. PubMed ID: 11402444
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
